ICU SeaStar Medical Holding Corporation - Common Stock
$3.81
Price · May 20, 2026
Fundamentals as of May 13, 2026
52W Range
$0–$5
74% of range
Analyst Rating
BUY
5 analysts
Price Target
$10
+162% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
ICU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.81
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $5
ICU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
ICU
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
ICU
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
ICU
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
ICU
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
ICU
Peer Median
ICU Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
5 analysts
- Strong Buy 1 20.0%
- Buy 3 60.0%
- Hold 1 20.0%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
2 analysts · 2026-05-15
Median
$10.00
← Below all targets
$3.81
Low
$8.00
High
$12.00
Median target
$10.00
+162.4%
Mean target
$10.00
+162.4%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.63%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.90 | $-0.83 | -0.07% |
| Dec. 31, 2025 | $-0.80 | $-1.07 | 0.27% |
| Sept. 30, 2025 | $-1.30 | $-1.51 | 0.21% |
| June 30, 2025 | $-1.80 | $-4.34 | 2.5% |
| March 31, 2025 | $-4.40 | $-5.25 | 0.85% |
| Dec. 31, 2024 | $-9.00 | $-8.99 | -0.01% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ICU | — | — | — | — | — | — |
| MODD | $59M | -2.1 | — | — | -137.7% | — |
| ADGM | $23M | -0.7 | — | — | -238.1% | — |
| IRIX | $20M | -4.5 | 8.2% | -8.4% | -80.8% | 36.5% |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 15
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue | $495.0K | $293.0K | |
| Cost of Revenue | $46.0K | $0 | |
| Gross Profit | $449.0K | $293.0K | |
| R&D Expense | $2M | $2M | |
| SG&A Expense | $2M | $2M | |
| Operating Expenses | $4M | $4M | |
| Operating Income | $-4M | $-4M | |
| Interest Income | $91.0K | $48.0K | |
| Other Non-op | $85.0K | $53.0K | |
| Pretax Income | $-4M | $-4M | |
| Income Tax | $3.0K | $3.0K | |
| Net Income | $-4M | $-4M | |
| EPS (Basic) | $-0.90 | $-4.38 | |
| Shares (Basic) | 3,918,339 | 861,794 | |
| EBITDA | $-4M | · |
Balance Sheet 19
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $9M | · | |
| Receivables | $179.0K | · | |
| Inventory | $57.0K | · | |
| Prepaid Expense | $1M | · | |
| Current Assets | $11M | · | |
| Other Non-current Assets | $499.0K | · | |
| Total Assets | $11M | · | |
| Accounts Payable | $719.0K | · | |
| Accrued Liabilities | $3M | · | |
| Short-term Debt | $331.0K | · | |
| Current Liabilities | $4M | · | |
| Total Liabilities | $4M | · | |
| Total Debt | $331.0K | · | |
| Common Stock | $4.0K | · | |
| Paid-in Capital | $163M | · | |
| Retained Earnings | $-155M | · | |
| Stockholders' Equity | $7M | · | |
| Liabilities + Equity | $11M | · | |
| Shares Outstanding | 3,993,719 | · |
Cash Flow 6
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Stock-based Comp | $91.0K | $167.0K | |
| Operating Cash Flow | $-3M | $-3M | |
| Stock Issued | $329.0K | $2M | |
| Net Stock Activity | $329.0K | · | |
| Financing Cash Flow | $129.0K | $6M | |
| Net Change in Cash | $-3M | $3M |
Profitability 8
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Gross Margin | 90.7% | · | |
| Operating Margin | -727.9% | · | |
| Net Margin | -711.3% | · | |
| Pretax Margin | -710.7% | · | |
| EBITDA Margin | -727.9% | · | |
| ROA | -37.3% | · | |
| ROE | -89.4% | · | |
| ROIC | -47.2% | · |
Liquidity & Solvency 3
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 2.7 | · | |
| Quick Ratio | 2.4 | · | |
| Debt / Equity | 0.0 | · |
Efficiency 3
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Asset Turnover | 0.1 | · | |
| Inventory Turnover | 0.9 | · | |
| Receivables Turnover | 3.4 | · |
Valuation (TTM) 12
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue TTM | $1M | · | |
| Net Income TTM | $-13M | · | |
| Market Cap | $15M | · | |
| Enterprise Value | $6M | · | |
| P/E | -1.4 | · | |
| P/S | 11.3 | · | |
| P/B | 2.0 | · | |
| P / Tangible Book | 2.0 | · | |
| P / Cash Flow | -5.4 | · | |
| EV / EBITDA | -1.6 | · | |
| EV / Revenue | 4.5 | · | |
| Earnings Yield | -73.9% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.